MK-3475-G21
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Immatics US, Inc.
Replimune Inc.
Bristol-Myers Squibb
Essen Biotech
Essen Biotech
Teva Branded Pharmaceutical Products R&D, Inc.
M.D. Anderson Cancer Center
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Inhibrx Biosciences, Inc
GV20 Therapeutics
Anaveon AG
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Novartis
NuCana plc
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
BioAtla, Inc.
Krystal Biotech, Inc.
Xynomic Pharmaceuticals, Inc.
Rabin Medical Center
GV20 Therapeutics
Immunophotonics, Inc.
OncoResponse, Inc.
Aminex Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Simcha IL-18, Inc.
Salubris Biotherapeutics Inc
Vector Vitale LLC
ENB Therapeutics, Inc
GlaxoSmithKline
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Apexigen America, Inc.
OncoResponse, Inc.
Kineta Inc.
Revolution Medicines, Inc.
4D pharma plc
Bristol-Myers Squibb
Innovent Biologics (Suzhou) Co. Ltd.
Ludwig Institute for Cancer Research
Akeso
Genocea Biosciences, Inc.
Effector Therapeutics
Lumos Pharma
Celgene
Incyte Corporation